Drugs / Peru-15
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00624975 | Nov 2008 → Jul 2012 | cholera, diarrheal disease | International Vaccine Institute | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Peru-15 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00624975 ↗ |
| Modality | Vaccine | “It is a live oral attenuated cholera vaccine” NCT00624975 ↗ |
| Route | Oral | “It is a live oral attenuated cholera vaccine” NCT00624975 ↗ |